Global Propionic Acidemia Treat Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Propionic Acidemia Treat Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Propionic Acidemia is a recessive genetic disorder in which the body is not able to make certain parts of lipids (fat) and protein properly. It is also known as an organic acid disorder, which causes an unusual buildup of particular organic acids in the body.
Propionic Acidemia Treat report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Propionic Acidemia Treat market is projected to reach US$ 565.4 million in 2029, increasing from US$ 310 million in 2022, with the CAGR of 8.9% during the period of 2024 to 2029. Demand from Hospital Pharmacies and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Propionic Acidemia Treat industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Propionic Acidemia Treat key companies include Cardiva Grifols SA, CSL Behring, Octapharma AG, Sanquin, Kedrion SpA, Shire and China Biologic Products Holdings, Inc, etc. Cardiva Grifols SA, CSL Behring, Octapharma AG are top 3 players and held % share in total in 2022.
Propionic Acidemia Treat can be divided into Intravenous Glucose Fluid Therapy, Antibiotics, Intravenous Bicarbonate and Biotin Supplement, etc. Intravenous Glucose Fluid Therapy is the mainstream product in the market, accounting for % share globally in 2022.
Propionic Acidemia Treat is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacy, Online Pharmacy and Others, etc. Hospital Pharmacies provides greatest supports to the Propionic Acidemia Treat industry development. In 2022, global % share of Propionic Acidemia Treat went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Propionic Acidemia Treat market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Cardiva Grifols SA
CSL Behring
Octapharma AG
Sanquin
Kedrion SpA
Shire
China Biologic Products Holdings, Inc
Segment by Type
Intravenous Glucose Fluid Therapy
Antibiotics
Intravenous Bicarbonate
Biotin Supplement
Others
Hospital Pharmacies
Retail Pharmacy
Online Pharmacy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Propionic Acidemia Treat market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Propionic Acidemia Treat introduction, etc. Propionic Acidemia Treat Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Propionic Acidemia Treat market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Propionic Acidemia Treat report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Propionic Acidemia Treat market is projected to reach US$ 565.4 million in 2029, increasing from US$ 310 million in 2022, with the CAGR of 8.9% during the period of 2024 to 2029. Demand from Hospital Pharmacies and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Propionic Acidemia Treat industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Propionic Acidemia Treat key companies include Cardiva Grifols SA, CSL Behring, Octapharma AG, Sanquin, Kedrion SpA, Shire and China Biologic Products Holdings, Inc, etc. Cardiva Grifols SA, CSL Behring, Octapharma AG are top 3 players and held % share in total in 2022.
Propionic Acidemia Treat can be divided into Intravenous Glucose Fluid Therapy, Antibiotics, Intravenous Bicarbonate and Biotin Supplement, etc. Intravenous Glucose Fluid Therapy is the mainstream product in the market, accounting for % share globally in 2022.
Propionic Acidemia Treat is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacy, Online Pharmacy and Others, etc. Hospital Pharmacies provides greatest supports to the Propionic Acidemia Treat industry development. In 2022, global % share of Propionic Acidemia Treat went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Propionic Acidemia Treat market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Cardiva Grifols SA
CSL Behring
Octapharma AG
Sanquin
Kedrion SpA
Shire
China Biologic Products Holdings, Inc
Segment by Type
Intravenous Glucose Fluid Therapy
Antibiotics
Intravenous Bicarbonate
Biotin Supplement
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacy
Online Pharmacy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Propionic Acidemia Treat market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Propionic Acidemia Treat introduction, etc. Propionic Acidemia Treat Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Propionic Acidemia Treat market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.